You touched many points with which I agree. One can never
You touched many points with which I agree. One can never count out what I feel are criminal naked shorters in this stock, their assets, or their determination to keep IPIX under their thumb. As much as I would like to believe the volume Fri (and for some days prior) was due to accumulators of the stock and possibly the company adding to its cash supply (it can't be doing all this work with no funds) the volume due to wash sales and naked shorters cannot be established or identified. I will not be completely free of worrying about their threat until a major deal is signed (expect it to be OM) with significant upfront monies that will provide us needed funds for operations thru the end of the year (at least). Come on LW, do your magic.
I do not believe the shorters can keep up the volume like Fri for many days as IMO I believe the naked shorts are already in the many tens of millions. If/when positive corona results come out and then the volume goes kattywumpus they will be history and lose control over the machinations of the share price, so they have to show some restraint.
As such, I will be looking at the volume this week much more than the share price movement. I have some dry powder and will be watching closely. Looking at buying more, not looking to do any trading as I have never sold a share to date.
The longer the corona threat goes on, the more I realize for the sake of the world that Brilacidin better be the answer as I feel there is not much else currently that could immediately be thrown into the fray for those most seriously affected by it and prevent their deaths and possibly fend off many portions of the world having to face quarantine conditions.
As I have posted before, Brilacidin should have potential revenue streams if the corona/respiratory results are very good (as we are expecting them to be) over $100B/yr when added to the already $43B/year for IBD alone.
Exciting times, but although we all like our odds for success there is still a bit of anxiety in the wind until B does prove out for corona.
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...
Continue Reading
Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...
Continue Reading
TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...
Continue Reading
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...
Continue Reading
Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....
Continue Reading
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
Top 5 Most Recently Viewed Articles
Revolutionizing Energy Generation from Pipelines Innovators are always seeking new ways to deliver sustainable energy solutions, and one recent idea has emerged that may change the way we think about power generation. An inventive thinker has designed a technology that utilizes pipelines, specifically those carrying fluid or gas, to generate electricity. This innovative...
Continue Reading
Elliott Hill Takes Charge at Nike Nike Inc. (NYSE: NKE) has appointed Elliott Hill as its new CEO. This decision aims to strengthen the brand's connections with retail partners and enhance sales efforts. What Led to the Change? Hill steps into this important role following the departure of John Donahoe, who implemented a direct-to-consumer sales model. While this approach...
Continue Reading
ImageneBio's New Era Begins with Merger and Funding Boost The merger between Inmagene Biopharmaceuticals and Ikena Oncology marks a significant milestone as the newly formed company, ImageneBio, Inc., is set to make its debut on Nasdaq with the ticker symbol ‘IMA’. This exciting transition underlines the commitment of ImageneBio to further develop innovative...
Continue Reading
Equity Lifestyle Properties' Earnings Expectations Equity Lifestyle Properties (ELS) is preparing for an upcoming quarterly earnings announcement that is highly anticipated by investors. This release is set to provide crucial insights into the company's financial health and projections for future growth. Analyst Predictions for Earnings Experts in the field forecast that...
Continue Reading
NexPoint Advocates for UDF IV Shareholders Amid Acquisition Talks NexPoint Real Estate Opportunities, LLC, along with its affiliates, has expressed its thoughts regarding the proposed acquisition of United Development Funding IV (UDF IV) by Ready Capital Corporation. This transaction highlights NexPoint's continued commitment to impacting shareholder value. Transaction...
Continue Reading
